title: Changes in brain β-amyloid deposition and aquaporin 4 levels in response to altered agrin expression in mice.
abstract: Conditions that compromise the blood-brain barrier (BBB) have been increasingly implicated in the pathogenesis of Alzheimer disease (AD). AGRIN is a heparan sulfate proteoglycan found abundantly in basement membranes of the cerebral vasculature, where it has been proposed to serve a functional role in the BBB. Furthermore, AGRIN is the major heparan sulfate proteoglycan associated with amyloid plaques in AD brains. To examine the relationship of AGRIN, the BBB, and AD-related pathologies, we generated mice in which the Agrn gene was deleted from either endothelial cells or neurons using gene targeting or was overexpressed using a genomic transgene construct. These mice were combined with a transgenic model of AD that over expresses disease-associated forms of amyloid precursor protein and presenilin 1. In mice lacking endothelial cell expression of Agrn, the BBB remained intact but aquaporin 4 levels were reduced, indicating that the loss of AGRIN affects BBB-associated components. This change in Agrn resulted in an increase in β-amyloid (Aβ) in the brain. Conversely, overexpression of Agrn decreased Aβ deposition, whereas elimination of Agrn from neurons did not change Aβ levels. These results indicate that AGRIN is important for maintaining BBB composition and that changes in Agrn expression (particularly vessel-associated AGRIN) influence Aβ homeostasis in mouse models of AD.
authors.affiliation: Jackson Laboratory, Bar Harbor, Maine 04609, USA.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Rauch
authors.forename: Kathy
authors.initials: K
authors.lastname: Huen
authors.forename: Miles C
authors.initials: MC
authors.lastname: Miller
authors.forename: Hira
authors.initials: H
authors.lastname: Chaudry
authors.forename: Melissa
authors.initials: M
authors.lastname: Lau
authors.forename: Joshua R
authors.initials: JR
authors.lastname: Sanes
authors.forename: Conrad E
authors.initials: CE
authors.lastname: Johanson
authors.forename: Edward G
authors.initials: EG
authors.lastname: Stopa
authors.forename: Robert W
authors.initials: RW
authors.lastname: Burgess
mesh_terms: D018171:Agrin / Q000235:genetics / Q000378:metabolism*; D000544:Alzheimer Disease / Q000235:genetics / Q000378:metabolism / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D000818:Animals; D051401:Aquaporin 4 / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000378:metabolism / Q000473:pathology; D001921:Brain / Q000378:metabolism* / Q000473:pathology; D042783:Endothelial Cells / Q000378:metabolism / Q000473:pathology; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D058225:Plaque, Amyloid / Q000378:metabolism / Q000473:pathology; D011950:Receptors, Cholinergic / Q000378:metabolism
chemical_list: D018171:Agrin; D016229:Amyloid beta-Peptides; D051401:Aquaporin 4; D011950:Receptors, Cholinergic
references.citation: J Neurochem. 1999 Apr;72(4):1681-7
references.pmid: 10098877
references.citation: Acta Neuropathol. 2006 Oct;112(4):405-15
references.pmid: 16865397
references.citation: Neuron. 2008 Jan 24;57(2):178-201
references.pmid: 18215617
references.citation: Neurology. 1996 Jun;46(6):1592-6
references.pmid: 8649554
references.citation: Neuroreport. 1995 Dec 29;7(1):297-301
references.pmid: 8742474
references.citation: Neuroscience. 2009 Mar 31;159(3):1055-69
references.pmid: 19356689
references.citation: J Neurol Sci. 2002 Nov 15;203-204:183-7
references.pmid: 12417381
references.citation: Neuron. 2004 Sep 2;43(5):605-8
references.pmid: 15339642
references.citation: Acta Neuropathol. 2004 Apr;107(4):311-8
references.pmid: 14735305
references.citation: Am J Pathol. 1988 Dec;133(3):456-63
references.pmid: 2974240
references.citation: Eur J Neurosci. 2007 Oct;26(8):2109-18
references.pmid: 17927773
references.citation: Radiology. 2009 Mar;250(3):856-66
references.pmid: 19164119
references.citation: Nat Genet. 1997 Oct;17(2):223-5
references.pmid: 9326948
references.citation: J Neuropathol Exp Neurol. 2002 Mar;61(3):282-93
references.pmid: 11895043
references.citation: J Cereb Blood Flow Metab. 2007 May;27(5):909-18
references.pmid: 17077814
references.citation: Acta Neuropathol. 2009 Jul;118(1):103-13
references.pmid: 19319544
references.citation: Brain Pathol. 2008 Apr;18(2):253-66
references.pmid: 18363936
references.citation: Am J Pathol. 2007 Jul;171(1):139-52
references.pmid: 17591961
references.citation: Brain Res. 2004 Aug 13;1017(1-2):130-6
references.pmid: 15261108
references.citation: Brain Res. 2008 Jun 24;1216:92-103
references.pmid: 18486110
references.citation: J Biol Chem. 1998 Jul 10;273(28):17832-8
references.pmid: 9651386
references.citation: Am J Pathol. 1999 Dec;155(6):2115-25
references.pmid: 10595940
references.citation: Alzheimer Dis Assoc Disord. 2002 Jul-Sep;16(3):191-5
references.pmid: 12218651
references.citation: Dev Biol. 2007 Mar 1;303(1):165-80
references.pmid: 17196957
references.citation: Cell Tissue Res. 2009 Aug;337(2):185-95
references.pmid: 19449033
references.citation: Neuromuscul Disord. 2003 Jun;13(5):408-15
references.pmid: 12798796
references.citation: Eur J Neurosci. 2011 Jun;33(12):2179-86
references.pmid: 21501259
references.citation: Amyloid. 2001 Jul;8 Suppl 1:10-9
references.pmid: 11676284
references.citation: Dev Dyn. 1997 Jan;208(1):62-74
references.pmid: 8989521
references.citation: Am J Pathol. 2001 Mar;158(3):1173-7
references.pmid: 11238065
references.citation: J Neuropathol Exp Neurol. 2009 Jan;68(1):1-14
references.pmid: 19104448
references.citation: Brain Res. 2009 Mar 13;1260:38-46
references.pmid: 19166823
references.citation: J Neurochem. 2007 Jun;101(5):1172-84
references.pmid: 17286590
references.citation: Brain Res. 2011 Jan 7;1367:2-12
references.pmid: 20920487
references.citation: Annu Rev Neurosci. 1999;22:389-442
references.pmid: 10202544
references.citation: Mol Cell Neurosci. 2001 Jan;17(1):208-25
references.pmid: 11161480
references.citation: Nat Med. 1998 Apr;4(4):452-5
references.pmid: 9546792
references.citation: J Cell Biol. 2000 Oct 2;151(1):41-52
references.pmid: 11018052
references.citation: J Neurochem. 2002 Oct;83(2):271-84
references.pmid: 12423238
references.citation: Dev Biol. 2001 Feb 15;230(2):230-42
references.pmid: 11161575
references.citation: Neurobiol Dis. 2003 Dec;14(3):318-27
references.pmid: 14678749
references.citation: J Biol Chem. 2009 Feb 20;284(8):4755-9
references.pmid: 18957434
references.citation: Neuropathol Appl Neurobiol. 2010 Oct;36(6):478-86
references.pmid: 20831743
references.citation: Amyloid. 2003 Jun;10(2):67-79
references.pmid: 12964414
references.citation: Physiol Rev. 2001 Apr;81(2):741-66
references.pmid: 11274343
references.citation: Proc Natl Acad Sci U S A. 1999 May 25;96(11):6468-72
references.pmid: 10339611
references.citation: Neuroscientist. 2009 Apr;15(2):180-93
references.pmid: 19307424
references.citation: Neurobiol Aging. 2000 Mar-Apr;21(2):349-55
references.pmid: 10867220
references.citation: Proc Natl Acad Sci U S A. 2007 Jan 16;104(3):823-8
references.pmid: 17215356
references.citation: Science. 2010 Dec 24;330(6012):1774
references.pmid: 21148344
references.citation: J UOEH. 2009 Sep 1;31(3):219-30
references.pmid: 19750929
references.citation: J Neurochem. 1997 Dec;69(6):2452-65
references.pmid: 9375678
references.citation: Mol Cell Neurosci. 2000 Feb;15(2):183-98
references.pmid: 10673326
references.citation: Hum Mol Genet. 2004 Jan 15;13(2):159-70
references.pmid: 14645205
references.citation: Acta Neuropathol. 2004 Feb;107(2):83-90
references.pmid: 14655019
references.citation: J Biol Chem. 2004 May 7;279(19):20296-306
references.pmid: 14985348